chondroitin-sulfates has been researched along with formic-acid* in 2 studies
2 other study(ies) available for chondroitin-sulfates and formic-acid
Article | Year |
---|---|
Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
In 2008, some 900 cases of adverse events associated with the use of heparin were reported to the Food and Drug Administration of USA and the Federal Institute of Drugs and Medical Devices in Germany. 238 patients died from heparin in the USA. In March 2008, oversulfated chondroitin sulfate (OSCS) was identified to be responsible for these cases. NMR spectroscopic evaluation of heparin samples revealed OSCS, dermatan sulfate (DS), chondroitin sulfate A and C as well as various residual solvents to be present in heparin batches, which could not be identified by means of conventional methods described in various pharmacopoeias at that time. In order to evaluate the situation on the German market, 145 representative samples were collected in 2008 and analyzed by means of 1H NMR spectroscopy, water determination, optical rotation and sheep plasma clotting assay. 66 samples were found to contain pure heparin, 51 samples heparin plus DS, 5 samples heparin plus OSCS, and 23 samples heparin, DS and OSCS, each in varying amounts. In 94 out of 145 batches especially ethanol was found in strongly varying amounts up to about 9.5%. Traces of acetone and formic acid were found with concentrations up to 0.04%, as well as sodium acetate and methanol up to 0.5%. Additionally, in many batches the content of water was found to be relatively high. Whereas the optical rotation was able to identify samples with a high contamination of OCSC, all samples tested fulfilled the requirements of the anticoagulation potency assay of the European Pharmacopoeia 6.0. The presented analysis of a representative set of heparin samples proves the suitability of 1H NMR spectroscopy for the quality control of heparin of both glycosaminoglycans and residual solvents. Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Chemistry, Pharmaceutical; Chondroitin Sulfates; Chromatography, High Pressure Liquid; Dermatan Sulfate; Drug Contamination; Formates; Germany; Heparin; Heparin, Low-Molecular-Weight; Magnetic Resonance Spectroscopy; Optical Rotation; Pharmacopoeias as Topic; Principal Component Analysis; Quality Control; Sodium Acetate; Solvents; Water | 2010 |
Characterization of the core protein of the large chondroitin sulfate proteoglycan synthesized by chondrocytes in chick limb bud cell cultures.
The core protein of high buoyant density proteoglycans synthesized by chondrocytes in stage 24 chick limb bud mesenchymal cell cultures was cleaved with cyanogen bromide to produce 17 resolvable peptides on sodium dodecyl sulfate-polyacrylamide slab gels. Of these peptides, 10 appear to originate from the chondroitin sulfate-rich region, 2 appear to be derived from the keratan sulfate-rich region, and 5 seem to be derived from the hyaluronic acid-binding region. The peptides from the chondroitin sulfate-rich region are almost all large (200 to 64 kDa). In contrast, the peptides from the keratan sulfate-rich and hyaluronic acid-binding regions are relatively small (47 to 12 kDa). One peptide from the hyaluronic acid-binding region appears to contain mannose-rich N-linked oligosaccharides as inferred from its observed binding by concanavalin A. A different hyaluronic acid-binding region peptide and one of the keratan sulfate-rich peptides were shown to contain disulfide bonds and therefore may be involved in contributing to the tertiary structure of the hyaluronic acid-binding region. Based on these observations, a map of the chick chondrocyte proteoglycan core protein has been constructed. Topics: Aggrecans; Animals; Carbohydrate Conformation; Cartilage; Cells, Cultured; Chick Embryo; Chondroitin Sulfates; Cyanogen Bromide; Disulfides; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix Proteins; Extremities; Formates; Glycoproteins; Hyaluronic Acid; Keratan Sulfate; Lectins, C-Type; Mannose; Mesoderm; Oligosaccharides; Peptide Fragments; Proteoglycans | 1987 |